Pharmaceutical company Merck & Co. Inc. is facing lawsuits that accuse the firm of downplaying potential negative psychiatric effects of its asthma medication Singulair, including thoughts of suicide. Singulair, also known as montelukast, was launched by Merck in 1998, with the product label stating that the drug’s distribution in the brain was “minimal.” The company…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`